Just a few years after mRNA vaccines proved their effectiveness against COVID-19, scientists are now looking at how they can be used to treat other serious diseases — including lung cancer. Researchers are beginning clinical trials using the technology to create a vaccine to treat non-small-cell lung cancer (NSCLC), the most common form of the disease.
Health
Scientists launch 1st lung cancer vaccine clinical trials using COVID-19 mRNA technology
More Videos
-
First Canadian case of more severe mpox strain confirmed in Manitoba
-
Health Matters: ‘Suicide pod’ creator rejects claim that 1st user was strangled
-
Genetics insights and AI-driven discoveries: Hope for the future of cancer
-
Health Matters: New Brunswick measles outbreak rises to 44 cases
-
Health Matters: WHO approves first mpox vaccine for kids
-
Stretch, strengthen, and Save with band workouts
You are viewing an Accelerated Mobile Webpage.
View Original Article